We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 128

End of German Olanzapine battle: Federal Supreme Court upholds patent
  • Bird & Bird
  • Germany
  • March 11 2009

On December 16, 2008 the Federal Supreme Court gave its judgment determining the validity of the Olanzapine patent, this was further to its revocation by the Federal Patent Court at first instance


Edwards Lifesciences AG v Cook Biotech Incorporated
  • Bird & Bird
  • United Kingdom
  • July 17 2009

Mr Justice Kitchin handed down a decision only four weeks after the hearing, finding Cook’s patent invalid and not infringed by Edwards’ SAPIEN heart valve


The Wellcome Foundation Ltd v Paranova Pharmazeutika Handels GmbH
  • Bird & Bird
  • Austria
  • March 11 2009

Following a reference from the Austrian Supreme Court, the ECJ ruled on two questions relating to the conditions applicable to repackaging of pharmaceutical products in a parallel imports case


UK Patents Court judgment in Dr Reddy’s Laboratories v Eli Lilly
  • Bird & Bird
  • United Kingdom
  • December 31 2008

In a judgment handed down in October of this year, the Patents Court (Mr Justice Floyd) upheld EP (UK) 0,454,436 (the “Patent”) which is owned by Eli Lilly and which protects the schizophrenia drug olanzapine


Preliminary injunctions in pharmaceutical patent actions
  • Bird & Bird
  • Italy
  • May 13 2009

By a decision of 15 April 2009 issued in a preliminary injunction proceeding, the Court of Milan held that the mere grant of a Marketing Authorisation (MA) for a generic pharmaceutical product does not constitute an imminent threat of patent infringement


Does requesting and receiving approval for a pharmaceutical create a threat of patent infringement? A German perspective
  • Bird & Bird
  • Germany
  • February 28 2008

Under German law, neither the application for a marketing approval nor obtaining it constitutes a ‘use’ act under Section 9 German Patent Act


Generics in France: towards an exemption from trade mark rights and a two-tier system?
  • Bird & Bird
  • France
  • December 15 2009

On 26 November 2009, the French Senate voted on the law on ‘Financing the National Social Security for 2010’


Patent decisions on patents for chiral compounds
  • Bird & Bird
  • United Kingdom
  • May 13 2009

A chiral compound is one which has at least one asymmetric carbon centre


UK Patents Court judgment in Laboratorios Almirall SA v Boehringer Ingelheim International GmbH
  • Bird & Bird
  • United Kingdom
  • March 11 2009

This case concerned a tit-for-tat revocation of two patents claiming the combinations of a particular anticholinergic with -agonists for treating respiratory illnesses


Patents Court judgment in Ratiopharm GmbH and Sandoz Limited v Napp Pharmaceutical Holdings Limited
  • Bird & Bird
  • United Kingdom
  • March 11 2009

The Patents Court (Mr Justice Floyd) handed judgment down on 16 December 2008 relating to two patents regarding formulations to achieve slow release of the opioid pain killing drug, oxycodone